Netherlands: Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Market Size in the Netherlands

The Dutch medicaments containing insulin market soared to $X in 2021, jumping by 25,131% against the previous year. Over the period under review, consumption recorded strong growth. Over the period under review, the market reached the maximum level at $X in 2019; however, from 2020 to 2021, consumption failed to regain momentum.

Medicaments Containing Insulin Production in the Netherlands

In value terms, medicaments containing insulin production stood at $X in 2021 estimated in export price. Over the period under review, production continues to indicate a sharp decrease. The pace of growth appeared the most rapid in 2019 with a decrease of -11.8% against the previous year. Over the period under review, production reached the maximum level at $X in 2017; however, from 2018 to 2021, production remained at a lower figure.

Medicaments Containing Insulin Exports

Exports from the Netherlands

In 2021, approx. X kg of medicaments containing insulin but not antibiotics were exported from the Netherlands; waning by -50.5% on the previous year. In general, exports recorded a dramatic decrease. The smallest decline of -37.9% was in 2019. The exports peaked at X tons in 2017; however, from 2018 to 2021, the exports failed to regain momentum.

In value terms, medicaments containing insulin exports surged to $X in 2021. Overall, exports showed a dramatic slump. Over the period under review, the exports attained the maximum at $X in 2017; however, from 2018 to 2021, the exports remained at a lower figure.

Exports by Country

The UK (X kg) was the main destination for medicaments containing insulin exports from the Netherlands, with a 63% share of total exports. Moreover, medicaments containing insulin exports to the UK exceeded the volume sent to the second major destination, the Czech Republic (X kg), fivefold. Germany (X kg) ranked third in terms of total exports with a 7.4% share.

From 2017 to 2021, the average annual rate of growth in terms of volume to the UK stood at +652.4%. Exports to the other major destinations recorded the following average annual rates of exports growth: the Czech Republic (+87.1% per year) and Germany (-86.0% per year).

In value terms, the UK ($X) emerged as the key foreign market for medicaments containing insulin but not antibiotics exports from the Netherlands, comprising 71% of total exports. The second position in the ranking was held by the Czech Republic ($X), with a 15% share of total exports. It was followed by Poland, with a 9.6% share.

From 2017 to 2021, the average annual rate of growth in terms of value to the UK stood at +6,321.5%. Exports to the other major destinations recorded the following average annual rates of exports growth: the Czech Republic (+538.6% per year) and Poland (+10.9% per year).

Export Prices by Country

In 2021, the average medicaments containing insulin export price amounted to $X per ton, rising by 433% against the previous year. In general, the export price saw a significant expansion. As a result, the export price reached the peak level and is likely to continue growth in the immediate term.

There were significant differences in the average prices for the major overseas markets. In 2021, amid the top suppliers, the country with the highest price was Poland ($X per ton), while the average price for exports to Germany ($X per ton) was amongst the lowest.

From 2017 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to Poland (+1,370.2%), while the prices for the other major destinations experienced more modest paces of growth.

Medicaments Containing Insulin Imports

Imports into the Netherlands

In 2021, the amount of medicaments containing insulin but not antibiotics imported into the Netherlands skyrocketed to X tons, with an increase of 20% against 2020. Over the period under review, imports showed a relatively flat trend pattern. The pace of growth appeared the most rapid in 2019 when imports increased by 1,876% against the previous year. As a result, imports attained the peak of X tons. From 2020 to 2021, the growth of imports remained at a somewhat lower figure.

In value terms, medicaments containing insulin imports reduced remarkably to $X in 2021. Overall, imports continue to indicate a remarkable increase. The most prominent rate of growth was recorded in 2019 with an increase of 2,192%. As a result, imports reached the peak of $X. From 2020 to 2021, the growth of imports failed to regain momentum.

Imports by Country

In 2021, Belgium (X tons) constituted the largest supplier of medicaments containing insulin to the Netherlands, accounting for a 90% share of total imports. Moreover, medicaments containing insulin imports from Belgium exceeded the figures recorded by the second-largest supplier, the UK (X kg), more than tenfold.

From 2012 to 2021, the average annual rate of growth in terms of volume from Belgium amounted to -55.2%. The remaining supplying countries recorded the following average annual rates of imports growth: the UK (0.0% per year) and Estonia (-32.1% per year).

In value terms, Belgium ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics to the Netherlands, comprising 78% of total imports. The second position in the ranking was held by Estonia ($X), with a 15% share of total imports.

From 2012 to 2021, the average annual growth rate of value from Belgium amounted to -40.8%. The remaining supplying countries recorded the following average annual rates of imports growth: Estonia (-11.8% per year) and the UK (0.0% per year).

Import Prices by Country

In 2021, the average medicaments containing insulin import price amounted to $X per ton, reducing by -68.5% against the previous year. Over the period under review, the import price, however, enjoyed a remarkable increase. The pace of growth appeared the most rapid in 2020 when the average import price increased by 454% against the previous year. As a result, import price reached the peak level of $X per ton, and then shrank dramatically in the following year.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Estonia ($X per ton), while the price for the UK ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Belgium (+32.1%).

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :